The BC Bud Co Closes Upsized 3rd and Final Tranche of Financing
Rhea-AI Summary
The BC Bud (BCBCF) has successfully closed the third and final tranche of its oversubscribed non-brokered private placement, raising $506,436 through the sale of 6,752,483 units at $0.075 per unit. Each unit includes one common share and one warrant exercisable at $0.15 for 24 months.
The company previously raised $631,300 in the first tranche and $511,275 in the second tranche, bringing total proceeds to $1,649,011 through 21,986,813 units. The third tranche involved finder's fees of $21,912 and 292,160 finder warrants.
Additionally, BCBCF plans to extend the expiry date of 6,800,000 prior warrants from February 2, 2025, to February 2, 2026, subject to CSE approval. The proceeds will be used for business development and working capital.
Positive
- Successfully raised total proceeds of $1,649,011 through oversubscribed placement
- All three tranches of financing completed, demonstrating strong investor interest
Negative
- Dilution of existing shareholders through issuance of 21,986,813 new units
- Additional potential dilution from exercise of warrants and finder warrants
News Market Reaction
On the day this news was published, BCBCF declined 0.24%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Vancouver, British Columbia--(Newsfile Corp. - January 29, 2025) - The BC Bud Corporation (CSE: BCBC) (OTC Pink: BCBCF) (FSE: W04) ("The BC Bud Co" or the "Company"), is pleased to announce that it has closed the third and final tranche of its oversubscribed previously announced non-brokered private placement (the "Placement") (see news releases dated January 9, 2025, January 17, 2025 and January 24, 2025).
Under the third tranche of the Placement, the Company raised gross proceeds of
In connection with the third tranche of the Placement, the Company: (i) paid to certain finders an aggregate cash commission of
All securities issued in the third tranche are subject to a statutory hold period expiring on May 30, 2025, in accordance with applicable securities legislation.
Net proceeds of the Placement will be utilized for business development and general working capital purposes.
Warrant Extension
The Company is also pleased to announce that it intends to extend the expiry date of an aggregate of 6,800,000 common share purchase warrants (the "Prior Warrants") issued under a previous non-brokered private placement completed on February 2, 2023. Each Prior Warrant is currently exercisable into one Common Share of the Company at an exercise price of
About The BC Bud Co.
The B.C. Bud Co. is a house of brands created by industry professionals who are passionate about the user experience.
On behalf of the board of directors of The BC Bud Co.
Brayden Sutton
Chief Executive Officer and Director
Investor Relations
Phone: 1-(778)-656-0377
Email: info@thebcbc.com
Web: www.thebcbc.com
Disclaimer
Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding the anticipated use of the net proceeds of the Placement, the Company's intention to complete the warrant extension and that the warrant extension will be effected. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.
In making the forward-looking statements in this news release, the Company has applied certain material assumptions, including without limitation, that the Company will use the net proceeds of the Placement as currently anticipated, that the Company will not run into regulatory or other barriers in carrying out its business plans, and that the Company will obtain all required corporate and regulatory approvals for the warrant extension. These forward‐looking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These risks and uncertainties include, among other things, that the Company will not use the net proceeds of the Placement as currently anticipated and that the Company may not obtain CSE and other required approvals to effect the warrant extension
Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/238894
FAQ
How much did The BC Bud Co (BCBCF) raise in its third tranche of financing?
What are the total proceeds raised by BCBCF across all three tranches?
What is the exercise price and expiry period for BCBCF's new warrants?
What is BCBCF planning to do with the 6,800,000 prior warrants from February 2023?
How will BCBCF use the proceeds from this financing?
